Abstracts tagged "tumor necrosis factor (TNF) and ultrasonography"

Abstract Number: 143 • 2014 ACR/ARHP Annual Meeting
Detailed Anatomical Distribution of Synovial Inflammation Revealed By Ultrasound in Patients with Blau Syndrome
Kei Ikeda¹, Naotomo Kambe², Syuji Takei^3,4, Taiji Nakano⁵, Yuzaburo Inoue⁵, Minako Tomiita⁶, Natsuko Oyake⁷, Takashi Satoh⁸, Tsuyoshi Yamatou³, Tomohiro Kubota³, Ikuo Okafuji⁹, Nobuo Kanazawa¹⁰, Ryuta Nishikomori¹¹, Naoki Shimojo⁵, Hiroyuki Matsue⁸ and Hiroshi Nakajima¹, ¹Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan, ²Dermatology, Chiba University Graduate School of Medicine, Chiba, Japan, ³Department of Pediatrics, Kagoshima University Hospital, Kagoshima, Japan, ⁴School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan, ⁵Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan, ⁶Department of Allergy and Rheumatology, Chiba Children’s Hospital, Chiba, Japan, ⁷Department of Pediatrics, Hitachinaka General Hospital, Hitachinaka, Japan, ⁸Department of Dermatology, Chiba University Graduate School of Medicine, Chiba, Japan, ⁹Department of Pediatrics, Kobe City Medical Center General Hospital, Kobe, Japan, ¹⁰Department of Dermatology, Wakayama Medical University, Wakayama, Japan, ¹¹Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Background/Purpose Arthritis is the most frequent manifestation of Blau syndrome, an autoinflammatory disorder caused by the genetic mutation of NOD2. However, the detailed information on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].